4//SEC Filing
MCGRAW BENJAMIN F III 4
Accession 0001209191-21-057288
CIK 0001337553other
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 5:40 PM ET
Size
7.6 KB
Accession
0001209191-21-057288
Insider Transaction Report
Form 4
MCGRAW BENJAMIN F III
Director
Transactions
- Award
Stock Option (right to buy)
2021-09-20+102,412→ 102,412 totalExercise: $11.59Exp: 2031-09-20→ Common Stock (102,412 underlying) - Award
Common Stock
2021-09-20+34,513→ 46,063 total
Footnotes (2)
- [F1]Subject to the reporting person's continued service as Interim Executive Chair through the vesting date, these shares of Common Stock are scheduled to vest on the earliest of (i) March 17, 2021 and (ii) the date on which the reporting person's service as Interim Executive Chair ceases following the company's appointment of a new CEO.
- [F2]Subject to the reporting person's continued service as Interim Executive Chair through the vesting date, this option is scheduled to vest on the earliest of (i) March 17, 2021 and (ii) the date on which the reporting person's service as Interim Executive Chair ceases following the company's appointment of a new CEO.
Documents
Issuer
AERIE PHARMACEUTICALS INC
CIK 0001337553
Entity typeother
Related Parties
1- filerCIK 0001216994
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 5:40 PM ET
- Size
- 7.6 KB